- Home » News and Events
NEWS & EVENTS
NEWS & EVENTS
Our newest offerings and capabilities. Recent investments in network capacity, new and expanded services and expertise. Upcoming conferences and events.
Catalent to Present Assessment Methods and Design Approaches for T-Cell Manufacturing Challenges at ISCT 2020 Virtual
May 20, 2020
Catalent today announced that Jean-François Chaubard, Senior Director, Open Innovation at Catalent Cell & Gene Therapy, will be presenting at the ISCT 2020 Paris Virtual conference.
Triphase Accelerator and Catalent Announce Interim Results of a Dose Escalation Phase 1 Clinical Trial of TRPH-222 in Patients with Non-Hodgkin’s Lymphoma
May 18, 2020
Triphase Accelerator and Catalent today announced interim results for Triphase Accelerator’s multi-center, open-label, monotherapy study of TRPH-222 in heavily pre-treated patients with relapsed and/or refractory B-cell lymphoma.
Arcturus Therapeutics and Catalent Announce Partnership to Manufacture mRNA-Based COVID-19 Vaccine
May 4, 2020
Arcturus and Catalent today announced a partnership to support the expected manufacture of Arcturus’ COVID-19 mRNA vaccine candidate, intended to protect against the SARS-CoV-2 coronavirus.
Catalent Announces Next Generation of Cell & Gene Therapy Leadership
Apr 30, 2020
Catalent today announced the appointment of Manja Boerman, Ph.D., to the role of President, Cell & Gene Therapy. In this new role, Dr. Boerman will lead all of Catalent’s cell & gene therapy businesses worldwide.
Catalent Signs Agreement with Johnson & Johnson to be U.S. Manufacturing Partner for Lead COVID-19 Vaccine Candidate
Apr 29, 2020
Catalent today announced a collaboration with Johnson & Johnson for large-scale commercial manufacturing at its facility in Bloomington, Indiana of Johnson & Johnson’s lead vaccine candidate for COVID-19.
Catalent Biologics Completes $14 Million Commercial Packaging Expansion at its Bloomington, Indiana Facility
Apr 23, 2020
Catalent today announced the completion of its $14 million expansion to increase the biologics packaging capabilities and capacity at its Bloomington, Indiana facility.
Catalent to Host Workshop Demonstrating Advantages of Integrated Biologics Development Solutions in London, U.K.
Feb 20, 2020
Catalent today announced it will host a one day workshop titled, “Achieving Integrated Biologics Development: Challenges and How to Tackle Them”.
Catalent and Zumutor Biologics Collaborate to Manufacture First-in-Class mAb to Treat Solid Tumors
Feb 11, 2020
Catalent today announced that it has signed an agreement with Zumutor Biologics, Inc., to manufacture Zumutor’s lead candidate, ZM008, for the treatment of solid tumors.
Catalent Completes Acquisition of MaSTherCell
Feb 10, 2020
Catalent, Inc. today announced that it had completed its acquisition of MaSTherCell Global Inc., positioning Catalent as a premier technology, development and manufacturing partner for innovators of advanced biotherapeutics.
ASCO Explained
Date: May 27 – June 1, 2020
Webinar: The Outlook for Cancer Gene Therapies
Date: June 1, 2020
BIO Digital
Date: June 8-11, 2020
BPI Theater at BIO Digital
Date: June 8-11, 2020
Endpoints at BIO Digital
Date: June 9, 2020
Webinar: Up to the Challenge: Manufacturing’s Central Role in the Cell and Gene Therapy Revolution
Date: June 22, 2020
Webinar: Clinical Readiness – Practical and Innovative Solutions for AAV Development and Manufacturing
Date: June 23, 2020
World Orphan Drug Congress
Date: August 24 – 26, 2020
PEGS Boston
Date: August 31- September 4, 2020
PBSS – Regulated Large Molecule Bioanalysis: Fundamentals, the New FDA Guidance and Beyond
Date: September 17-19, 2020
BioProcess International
Date: September 21-24, 2020
World Vaccine Congress
Date: September 27-29, 2020
PDA Universe of Pre-Filled Syringes and Injection Devices
Date: October 5-6, 2020
Cell Culture Engineering XVII
Date: November 1-6, 2020
Gene Therapy for Rare Disorders
Date: February 22-25, 2021
ISOBiotech Spring Meeting
Date: March 15-17, 2021
Interphex
Date: April 20-22, 2021